Literature DB >> 26039773

Fifty Years of Technological Innovation: Potential and Limitations of Current Technologies in Abdominal Magnetic Resonance Imaging and Computed Tomography.

Ulrike I Attenberger1, John Morelli, Johannes Budjan, Thomas Henzler, Steven Sourbron, Michael Bock, Philipp Riffel, Diego Hernando, Melissa M Ong, Stefan O Schoenberg.   

Abstract

Magnetic resonance imaging (MRI) has become an important modality for the diagnosis of intra-abdominal pathology. Hardware and pulse sequence developments have made it possible to derive not only morphologic but also functional information related to organ perfusion (dynamic contrast-enhanced MRI), oxygen saturation (blood oxygen level dependent), tissue cellularity (diffusion-weighted imaging), and tissue composition (spectroscopy). These techniques enable a more specific assessment of pathologic lesions and organ functionality. Magnetic resonance imaging has thus transitioned from a purely morphologic examination to a modality from which image-based disease biomarkers can be derived. This fits well with several emerging trends in radiology, such as the need to accurately assess response to costly treatment strategies and the need to improve lesion characterization to potentially avoid biopsy. Meanwhile, the cost-effectiveness, availability, and robustness of computed tomography (CT) ensure its place as the current workhorse for clinical imaging. Although the lower soft tissue contrast of CT relative to MRI is a long-standing limitation, other disadvantages such as ionizing radiation exposure have become a matter of public concern. Nevertheless, recent technical developments such as dual-energy CT or dynamic volume perfusion CT also provide more functional imaging beyond morphology.The aim of this article was to review and discuss the most important recent technical developments in abdominal MRI and state-of-the-art CT, with an eye toward the future, providing examples of their clinical utility for the evaluation of hepatic and renal pathologies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26039773     DOI: 10.1097/RLI.0000000000000173

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  5 in total

1.  MRI morphologic alterations after liver SBRT : Direct dose correlation with intermodal matching.

Authors:  Judit Boda-Heggemann; Ulrike Attenberger; Johannes Budjan; Anika Jahnke; Lennart Jahnke; Lena Vogel; Anna O Simeonova-Chergou; Carsten Herskind; Frederik Wenz; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2016-07-08       Impact factor: 3.621

Review 2.  [CT and MRI of the liver: when, what, why?]

Authors:  J Budjan; S O Schoenberg; U I Attenberger
Journal:  Radiologe       Date:  2017-05       Impact factor: 0.635

3.  The Evaluation of Zoomed Echo-Planar Diffusion-Weighted Magnetic Resonance Imaging With Two-dimensional Spatial-Selective Radiofrequency Excitation Pulses in Patients With Hilar Cholangiocarcinoma.

Authors:  Jingjing Liu; Mengyue Huang; Yanan Ren; Man Xu; Yinhua Li; Jingliang Cheng; Jinxia Zhu
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

Review 4.  BOLD magnetic resonance imaging in nephrology.

Authors:  Michael E Hall; Jennifer H Jordan; Luis A Juncos; W Gregory Hundley; John E Hall
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-03-13

5.  Discriminating chronic pancreatitis from pancreatic cancer: Contrast-enhanced EUS and multidetector computed tomography in direct comparison.

Authors:  Finn-J Rn Harmsen; Dirk Domagk; Christoph F Dietrich; Michael Hocke
Journal:  Endosc Ultrasound       Date:  2018 Nov-Dec       Impact factor: 5.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.